147 related articles for article (PubMed ID: 9008331)
1. Experimental autoimmune cystitis in the Lewis rat: a potential animal model for interstitial cystitis.
Luber-Narod J; Austin-Ritchie T; Banner B; Hollins C; Maramag C; Price H; Menon M
Urol Res; 1996; 24(6):367-73. PubMed ID: 9008331
[TBL] [Abstract][Full Text] [Related]
2. Experimental autoimmune cystitis: a potential murine model for ulcerative interstitial cystitis.
Bullock AD; Becich MJ; Klutke CG; Ratliff TL
J Urol; 1992 Dec; 148(6):1951-6. PubMed ID: 1433651
[TBL] [Abstract][Full Text] [Related]
3. Establishment of a Novel Autoimmune Experimental Model of Bladder Pain Syndrome/Interstitial Cystitis in C57BL/6 Mice.
Jin XW; Liu BK; Zhang X; Zhao ZH; Shao Y
Inflammation; 2017 Jun; 40(3):861-870. PubMed ID: 28233078
[TBL] [Abstract][Full Text] [Related]
4. Autoimmunity to uroplakin II causes cystitis in mice: a novel model of interstitial cystitis.
Altuntas CZ; Daneshgari F; Sakalar C; Goksoy E; Gulen MF; Kavran M; Qin J; Li X; Tuohy VK
Eur Urol; 2012 Jan; 61(1):193-200. PubMed ID: 21719190
[TBL] [Abstract][Full Text] [Related]
5. Autoimmunity to urothelial antigen causes bladder inflammation, pelvic pain, and voiding dysfunction: a novel animal model for Hunner-type interstitial cystitis.
Akiyama Y; Yao JR; Kreder KJ; O'Donnell MA; Lutgendorf SK; Lyu D; Maeda D; Kume H; Homma Y; Luo Y
Am J Physiol Renal Physiol; 2021 Feb; 320(2):F174-F182. PubMed ID: 33308017
[TBL] [Abstract][Full Text] [Related]
6. Gabapentin reduces painful bladder hypersensitivity in rats with lipopolysaccharide-induced chronic cystitis.
Yoshizumi M; Watanabe C; Mizoguchi H
Pharmacol Res Perspect; 2021 Feb; 9(1):e00697. PubMed ID: 33340266
[TBL] [Abstract][Full Text] [Related]
7. Lower urinary tract phenotype of experimental autoimmune cystitis in mouse: a potential animal model for interstitial cystitis.
Lin YH; Liu G; Kavran M; Altuntas CZ; Gasbarro G; Tuohy VK; Daneshgari F
BJU Int; 2008 Dec; 102(11):1724-30. PubMed ID: 18710451
[TBL] [Abstract][Full Text] [Related]
8. Experimental autoimmune cystitis: further characterization and serum autoantibodies.
Mitra S; Dagher A; Kage R; Dagher RK; Luber-Narod J
Urol Res; 1999 Oct; 27(5):351-6. PubMed ID: 10550523
[TBL] [Abstract][Full Text] [Related]
9. An Immunogenic Peptide, T2 Induces Interstitial Cystitis/Painful Bladder Syndrome: an Autoimmune Mouse Model for Interstitial Cystitis/Painful Bladder Syndrome.
Zhang L; Ihsan AU; Cao Y; Khan FU; Cheng Y; Han L; Zhou X
Inflammation; 2017 Dec; 40(6):2033-2041. PubMed ID: 28799018
[TBL] [Abstract][Full Text] [Related]
10. The c-Jun N-terminal kinase (JNK) pathway is activated in human interstitial cystitis (IC) and rat protamine sulfate induced cystitis.
Zhao J; Wang L; Dong X; Hu X; Zhou L; Liu Q; Song B; Wu Q; Li L
Sci Rep; 2016 Feb; 6():19670. PubMed ID: 26883396
[TBL] [Abstract][Full Text] [Related]
11. Cystitis-induced bladder pain is Toll-like receptor 4 dependent in a transgenic autoimmune cystitis murine model: a MAPP Research Network animal study.
Cui X; Jing X; Lutgendorf SK; Bradley CS; Schrepf A; Erickson BA; Magnotta VA; Ness TJ; Kreder KJ; O'Donnell MA; Luo Y
Am J Physiol Renal Physiol; 2019 Jul; 317(1):F90-F98. PubMed ID: 31091120
[TBL] [Abstract][Full Text] [Related]
12. The Effects of Neurokinin-1 Receptor Antagonist in an Experimental Autoimmune Cystitis Model Resembling Bladder Pain Syndrome/Interstitial Cystitis.
Liu BK; Jin XW; Lu HZ; Zhang X; Zhao ZH; Shao Y
Inflammation; 2019 Feb; 42(1):246-254. PubMed ID: 30196377
[TBL] [Abstract][Full Text] [Related]
13. Biopsy features are associated with primary symptoms in interstitial cystitis: results from the interstitial cystitis database study.
Tomaszewski JE; Landis JR; Russack V; Williams TM; Wang LP; Hardy C; Brensinger C; Matthews YL; Abele ST; Kusek JW; Nyberg LM;
Urology; 2001 Jun; 57(6 Suppl 1):67-81. PubMed ID: 11378053
[TBL] [Abstract][Full Text] [Related]
14. Peroxisome proliferator-activated receptor gamma agonist as a novel treatment for interstitial cystitis: A rat model.
Mahal A; Young-Lin N; Dobberfuhl A; Estes J; Comiter CV
Investig Clin Urol; 2018 Jul; 59(4):257-262. PubMed ID: 29984341
[TBL] [Abstract][Full Text] [Related]
15. Evidence for the Role of Mast Cells in Cystitis-Associated Lower Urinary Tract Dysfunction: A Multidisciplinary Approach to the Study of Chronic Pelvic Pain Research Network Animal Model Study.
Wang X; Liu W; O'Donnell M; Lutgendorf S; Bradley C; Schrepf A; Liu L; Kreder K; Luo Y
PLoS One; 2016; 11(12):e0168772. PubMed ID: 28002455
[TBL] [Abstract][Full Text] [Related]
16. Intravesical hyaluronidase causes chronic cystitis in a rat model: a potential model of bladder pain syndrome/interstitial cystitis.
Lv YS; Yao YS; Rong L; Lin ME; Deng BH; Xie Y; Huang H; Lin TX; Xu KW; Huang J
Int J Urol; 2014 Jun; 21(6):601-7. PubMed ID: 24286489
[TBL] [Abstract][Full Text] [Related]
17. Uroplakin peptide-specific autoimmunity initiates interstitial cystitis/painful bladder syndrome in mice.
Izgi K; Altuntas CZ; Bicer F; Ozer A; Sakalar C; Li X; Tuohy VK; Daneshgari F
PLoS One; 2013; 8(8):e72067. PubMed ID: 23977210
[TBL] [Abstract][Full Text] [Related]
18. Mast cell involvement in interstitial cystitis: a review of human and experimental evidence.
Theoharides TC; Kempuraj D; Sant GR
Urology; 2001 Jun; 57(6 Suppl 1):47-55. PubMed ID: 11378050
[TBL] [Abstract][Full Text] [Related]
19. RDP58 inhibits T cell-mediated bladder inflammation in an autoimmune cystitis model.
Liu W; Deyoung BR; Chen X; Evanoff DP; Luo Y
J Autoimmun; 2008 Jun; 30(4):257-65. PubMed ID: 18162370
[TBL] [Abstract][Full Text] [Related]
20. Treatment with low-energy shock wave alleviates pain in an animal model of uroplakin 3A-induced autoimmune interstitial cystitis/painful bladder syndrome.
Li H; Zhang Z; Peng J; Xin Z; Li M; Yang B; Fang D; Tang Y; Guo Y
Investig Clin Urol; 2019 Sep; 60(5):359-366. PubMed ID: 31501798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
